Clinical Trials for Janssen Biotech

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Janssen Biotech

Clinical Trials (9)

NCT05290363
The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis
NARecruiting
90 participants
Started: Oct 6, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors4 locations
NCT05300451
Daratumumab in HLA Desensitization Prior to Transplantation
PHASE2Enrolling by invitation
6 participants
Started: Mar 31, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05111210
Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
N/ARecruiting
90 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT04645355
Guselkumab Immunogenetics
PHASE4Recruiting
25 participants
Started: Mar 1, 2021 · Completed: Jan 1, 2025
2 conditions2 sponsors1 location
NCT03229200
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
PHASE4Enrolling by invitation
600 participants
Started: May 22, 2017 · Completed: May 10, 2027
5 conditions2 sponsors98 locations
NCT02808780
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
N/AActive, not recruiting
537 participants
Started: Dec 16, 2016 · Completed: Mar 11, 2027
1 condition1 sponsor63 locations
NCT02315326
Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
PHASE1/PHASE2Recruiting
109 participants
Started: Dec 31, 2014 · Completed: Dec 31, 2026
2 conditions3 sponsors7 locations
NCT02103361
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
N/ARecruiting
200 participants
Started: Nov 30, 2013 · Completed: Feb 28, 2031
4 conditions3 sponsors1 location
NCT00606346
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
N/AActive, not recruiting
4,970 participants
Started: May 31, 2007 · Completed: Jun 30, 2038
4 conditions1 sponsor62 locations